DRIO Share Price Performance
US$7.50
-6.80 (-47.56%)
60.1% undervalued intrinsic discount
US$18.80
Fair Value
Price US$7.50
AnalystConsensusTarget US$18.80
AnalystHighTarget US$28.00
AnalystLowTarget US$12.00
Fair ValueUS$18.80
Share Pricen/a
DarioHealth Corp. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 4 Fair Values set on narratives written by author
DRIO Community Narratives
AN
Fair Value
·Fair Value US$18.8 60.1% undervalued intrinsic discount
DRIO: New Client Wins And Pricing Initiatives Will Drive Upside Potential
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
Fair Value
·Fair Value US$28 73.2% undervalued intrinsic discount
Aging Demographics And Telehealth Will Transform Chronic Care
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value US$12 37.5% undervalued intrinsic discount
Digital Health Onboarding Delays And Rising Costs Will Ease Eventually
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Aging Demographics And Telehealth Will Transform Chronic Care
Key Takeaways Industry-leading outcomes, platform expansion, and entry into new care verticals position DarioHealth for accelerated market share and significant long-term revenue growth. Broad AI integration and premium-based reimbursement unlock major operating efficiencies and new revenue streams, driving margin expansion and improved earnings visibility.Read more
AN
US$28
73.2% undervalued intrinsic discount
Fair Value
Profit Margin
0.96%
Future PE
524.57x
Price in 2029
US$33.15
DRIO: New Client Wins And Pricing Initiatives Will Drive Upside Potential
Key Takeaways Shifting focus to high-margin recurring revenue and expanding into digital chronic care markets, with strong early traction in new platform segments. AI-driven operational efficiencies and signed large health plan deals set the stage for improved profitability and accelerated revenue growth in coming years.Read more
AN
US$18.8
60.1% undervalued intrinsic discount
Fair Value
Profit Margin
6.37%
Future PE
57.81x
Price in 2029
US$22.24
Digital Health Onboarding Delays And Rising Costs Will Ease Eventually
Key Takeaways Persistent onboarding delays and client turnover risk short-term revenue, while macroeconomic uncertainty and enterprise budget constraints may limit new customer growth. Margin gains via AI and analytics are offset by the need for sustained R&D investment and sector challenges that delay profitability and consistent earnings growth.Read more
AN
US$12
37.5% undervalued intrinsic discount
Fair Value
Profit Margin
8.77%
Future PE
10.62x
Price in 2028
US$6.65
Trending Discussion
Recently Updated Narratives
AN
DRIO: Peer Reviewed Outcomes And GLP 1 Tools Will Support Future Rebound
Fair Value: US$28 73.2% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
DRIO: AI Health Platform And Governance Changes Will Support 2026 Recovery
Fair Value: US$18.8 60.1% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Digital Health Onboarding Delays And Rising Costs Will Ease Eventually
Fair Value: US$12 37.5% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
DarioHealth Corp. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -5.52
- 64.11%
- -180.28%
- 45.3%
About DRIO
- Founded
- 2011
- Employees
- 163
- CEO
- WebsiteView website
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
